Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study was designed to assess the safety and efficacy of GW813893 in the prophylaxis of
VTE following TKR and to provide evidence to enable the selection of the appropriate dose(s)
and dose regimen of GW813893 for future investigation.